| Characteristic | Patients | ||||
| All (n = 193) | Prescribed statin (n = 183) | Not prescribed statin (n = 10) | Prescribed ACEI/ARB or CCB (n = 170) | Not prescribed ACEI/ARB or CCB (n = 23) | |
| Age (y) |
|
|
|
|
|
| Mean ± SD | 59.2 ± 13 | 59.6 ± 12.6 | 52.7 ± 11.4 | 59.4 ± 12.4 | 57.8 ± 16.9 |
| Range | 19.8 - 88.9 | 19.8 - 88.9 | 21.7 - 72.8 | 22.4 - 88.9 | 19.8 - 75.6 |
| Gender, male (%) | 148 (76.7) | 142 (77.6) | 6 (60) | 129 (75.9) | 19 (82.6) |
| Height (cm) |
|
|
|
|
|
| Mean ± SD | 171.8 ± 9.0 | 171.8 ± 9.0 | 171.8 ± 9.8 | 172.0 ± 8.9 | 170.4 ± 9.3 |
| Range | 147.5 - 193 | 147.5 - 193 | 157 - 186 | 147.5 - 193 | 152 - 183 |
| Weight (kg) |
|
|
|
|
|
| Mean ± SD | 84.2 ± 19 | 84.0 ± 18.5 | 87.4 ± 28 | 84.9 ± 19.4 | 78.3 ± 15.4 |
| Range | 31.4 - 151.6 | 48.2 - 151.6 | 31.4 - 131.8 | 31.4 - 151.6 | 48.8 - 113.2 |
| Time since transplant (y) |
|
|
|
|
|
| Mean ± SD | 8.2 ± 4.8 | 8.2 ± 4.9 | 8.2 ± 2.2 | 8.2 ± 4.7 | 8.2 ± 5.3 |
| Range | 0.1 - 22.6 | 0.1 - 22.6 | 4.7 - 12.1 | 0.5 - 22.6 | 0.1 - 19.5 |
| Indication for transplant, n (%) |
|
|
|
|
|
| CAD | 92 (50.3) | 87 (47.5) | 5 (50) | 81 (47.6) | 11 (47.8) |
| CM | 75 (38.9) | 71 (38.8) | 4 (40) | 67 (39.4) | 8 (34.8) |
| Dilated CM | 42 (21.8) | 39 (21.3) | 3 (30) | 38 (22.4) | 4 (17.4) |
| Idiopathic CM | 23 (11.9) | 23 (12.6) | 0 | 20 (11.8) | 3 (13) |
| Hypertrophic CM | 5 (2.6) | 5 (2.7) | 0 | 4 (2.4) | 1 (4.3) |
| ACAD-repeat OHT | 7 (3.6) | 7 (3.8) | 0 | 6 (3.5) | 1 (4.3) |
| Others | 19 (9.8) | 18 (9.8) | 1 (10) | 16 (9.4) | 3 (13) |
| Immunosuppressive regimen, n (%) |
|
|
|
|
|
| Cyclosporine | 119 (61.7) | 114 (62.3) | 5 (50) | 105 (61.8) | 14 (60.9) |
| Tacrolimus | 73 (37.8) | 69 (37.7) | 4 (40) | 64 (37.6) | 9 (39.1) |
| MMF | 135 (69.9) | 126 (68.9) | 9 (90) | 120 (70.6) | 15 (65.2) |
| Azathioprine | 27 (14) | 27 (14.8) | 0 | 24 (15.1) | 3 (13.0) |
| Corticosteroid | 40 (20.7) | 36 (19.7) | 4 (40) | 32 (18.8) | 8 (34.8) |
| Sirolimus | 21 (10.9) | 19 (9.8) | 2 (20) | 18 (10.6) | 3 (13) |
| Everolimus | 3 (1.6) | 3 (1.6) | 0 | 2 (1.3) | 1 (4.3) |
| ACAD, n (%) | 43 (22.3) | 40 (21.9) | 3 (30) | 36 (21.2) | 7 (30.4) |
| Lipid (mmol/L); mean ± SD |
|
|
|
|
|
| TC | 3.67 ± 0.77 | 3.63 ± 0.69 | 4.35 ± 1.57 | - | - |
| TG | 1.61± 1.04 | 1.63 ± 1.03 | 1.48 ± 1.27 | - | - - - - |
| HDL-C | 1.12 ± 0.39 | 1.11 ± 0.37 | 1.24 ± 0.62 | - | |
| LDL-C | 1.81 ± 0.55 | 1.78 ± 0.49 | 2.43 ± 1.09 | - | |
| TC:HDL-C | 3.53 ± 1.05 | 3.49 ± 1.00 | 4.05 ± 1.75 | - | |
| BP (mmHg) |
|
|
|
|
|
| SBPa | 124.2 ± 13.6 | - | - | 124.6 ± 13.9 | 121.7 ± 11.1 |
| DBPa | 77.8 ± 8.2 | - | - | 77.8 ± 8.1 | 77.9 ± 8.3 |